PRN: Elsevier Launches New Procedures Consult App for iPad, iPhone & iPod Touch
PRN: Elsevier Launches New Procedures Consult App for iPad, iPhone & iPod Touch.
Elsevier Launches New Procedures Consult App for iPad, iPhone & iPod Touch
PHILADELPHIA, December 5, 2011 /PRNewswire/ --
Optimized for quick, on-demand resource - including instructional videos - for medical professionals
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that itsÂ new Procedures Consult App for iPad, iPhone and iPod Touch is now available on the App Store. The app allows for procedure videos, illustrations and text to beÂ stored on a user's iOS device with customized user interfaces. Doctors can now work more confidently with whenever, wherever access to the critical and reliableÂ content of Procedures Consult, including at the bedside.
The Procedures Consult App delivers a single resource of high quality videos for all procedures required by theÂ American Board of Internal Medicine (ABIM), and conforms to the Accreditation Council for Graduate MedicalÂ Education (ACGME). It enables physicians, residents and medical students to more confidently perform theseÂ procedures, such as a subclavian line insertion or lumbar puncture, improving patient safety and helping to achieve theÂ best patient outcomes.
"The Procedures Consults App is unmatched in its breadth of coverage and the quality of the videos it delivers,Â providing incredible value to physicians at the point of care," said Randy Charles, Managing Director, Global ClinicalÂ Reference, Elsevier. "In addition to offering anytime and anywhere access to content, the Procedures Consult App alsoÂ saves valuable time due to its mobile-friendly, easy-to-learn navigation, enabling better decision-making and ultimatelyÂ moving critical content to the point of care."
Unique features of the Procedures Consult App include:
The Procedures Consult App is available for free from the App Store on iPad, iPhone or iPod Touch or atÂ http://www.iTunes.com/appstore.Â
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care ins! titutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Company Codes: LSE:REL, NYSE:RUK, NYSE:ENL